Bellevue, Washington
CNS medication trials in Bellevue, WA
26 CNS medication studies are recruiting participants at sites in Bellevue as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Bellevue at a glance
- 26 studies are recruiting at a site in Bellevue.
- By phase: Phase 2 (11), Phase 2/3 (1), Phase 3 (14).
- By sponsor: industry (26).
- By research area: Depression (13), Schizophrenia (8), Migraine (2), ADHD (1), Bipolar Disorder (1), Parkinson's Disease (1).
- Most recent update to one of these records: November 12, 2026.
Depression studies recruiting in Bellevue
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT07412756 · updated
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT05850689 · updated
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT06372964 · updated
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT07573176 · updated
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT07716098 · updated
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT07775300 · updated
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Draig Therapeutics Ltd
- Study site
- Draig Clinical Site
- Registry record
- NCT07610473 · updated
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Draig Therapeutics Ltd
- Study site
- Draig Clinical Site
- Registry record
- NCT07300969 · updated
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT06830044 · updated
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Study site
- Northwest Clinical Research Center /ID# 272847
- Registry record
- NCT06696755 · updated
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- LB Pharmaceuticals Inc.
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT07494305 · updated
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Study site
- Northwest Clinical Research Center /ID# 277484
- Registry record
- NCT07276997 · updated
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Autobahn Therapeutics, Inc.
- Study site
- Autobahn Site #143
- Registry record
- NCT06633016 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Bellevue, WA on ClinicalTrials.gov.
Schizophrenia studies recruiting in Bellevue
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT06887192 · updated
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT06229210 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT06540833 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT06585787 · updated
A Study of Brenipatide in Adult Participants With Schizophrenia
- Phase 2
- Ages 18 to 55
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT07410507 · updated
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07114874 · updated
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07227818 · updated
Randomized Withdrawal Study in Patients With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT06961968 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Bellevue, WA on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Bellevue
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT07286175 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Bellevue, WA on ClinicalTrials.gov.
ADHD studies recruiting in Bellevue
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07755410 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Bellevue, WA on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Bellevue
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Phase 2/3
- Ages 40 to 80
- All sexes
- Sponsor
- Biohaven Therapeutics Ltd.
- Registry record
- NCT06976268 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Bellevue, WA on ClinicalTrials.gov.
Migraine studies recruiting in Bellevue
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Northwest Clinical Research Center
- Registry record
- NCT04743141 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Bellevue, WA on ClinicalTrials.gov.
Ask about studies near Bellevue
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Washington
All Washington locations
63 studies recruiting across 7 cities.
Seattle
23 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections